Skip to main content

and
  1. No Access

    Article

    Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors

    In this study, we investigated the safety and efficacy in cancer patients of a single intra-tumor injection of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene (AdV/TK) followe...

    F Xu, S Li, X-L Li, Y Guo, B-Y Zou, R Xu, H Liao, H-Y Zhao, Y Zhang in Cancer Gene Therapy (2009)